Jeoung-Yeol Park

50PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthReproductionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 26, 2026
Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort study.

|Jul 23, 2026
Neoadjuvant Paclitaxel-Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes.

|Jul 06, 2026
Impact of fertility preservation on quality of life, recurrence and reproductive success in young female cancer survivors: a Korean prospective multicentre cohort study protocol (LIFE-Repro).

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 23, 2026
Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA.

Sung Jong Lee, Ji Geun Yoo, Jin Hwi Kim

|Jan 09, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).

Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi

Pageof 9

Frequent Collaborators

14 joint publications

Dong Hoon Suh

13 joint publications

Jae-Weon Kim

12 joint publications

Jung-Yun Lee

9 joint publications

Yoo-Young Lee